Company Response to NSE Volume Query
Date of Communication: September 09, 2026
Nature of Query: Clarification on movement in volume as requested by National Stock Exchange of India Limited
Company's Clarification on Trading Volume
The Company received a communication from the National Stock Exchange of India Limited (NSE) dated September 09, 2026 seeking clarification on movement in volume of the company's shares. In response, Corona Remedies Limited stated that the increase in trading volume is "purely market driven" and not attributable to any company-specific undisclosed information.
Regulatory Compliance Statement
The Company confirmed it is in full compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015. The Company stated it has been "promptly informing the Stock Exchanges on all events and information, which have a bearing on operation or performance of the Company."
Disclosure Status
The Company explicitly stated: "There is no undisclosed / price sensitive information or any impending announcement / corporate action which needs to be informed to the exchange at this point of time." The Company further reaffirmed its commitment to continue making disclosures in compliance with its obligations under Regulation 30 of the SEBI Listing Regulations.